Original Article
Outcomes of patients in the national cancer database treated non-surgically for localized rectal cancer
Journal of Gastrointestinal Oncology
2018;
9
(4)
:589-600
.
(01 August 2018)
Trends and disparities in the utilization of hypofractionated neoadjuvant radiation therapy for rectal cancer in the United States
Journal of Gastrointestinal Oncology
2018;
9
(4)
:601-609
.
(01 August 2018)
Beyond microsatellite testing: assessment of tumor mutational burden identifies subsets of colorectal cancer who may respond to immune checkpoint inhibition
Journal of Gastrointestinal Oncology
2018;
9
(4)
:610-617
.
(01 August 2018)
Impact of intensity modulated radiation therapy on survival in anal cancer
Journal of Gastrointestinal Oncology
2018;
9
(4)
:618-630
.
(01 August 2018)
The value of oxaliplatin in the systemic treatment of locally advanced rectal cancer
Journal of Gastrointestinal Oncology
2018;
9
(4)
:631-640
.
(01 August 2018)
Neoadjuvant PET and MRI-based intensity modulated radiotherapy leads to less toxicity and improved pathologic response rates in locally advanced rectal cancer
Journal of Gastrointestinal Oncology
2018;
9
(4)
:641-649
.
(01 August 2018)
A case-control study of the association between metabolic syndrome and colorectal cancer: a comparison of International Diabetes Federation, National Cholesterol Education Program Adults Treatment Panel III, and World Health Organization definitions
Journal of Gastrointestinal Oncology
2018;
9
(4)
:650-663
.
(01 August 2018)
Outcome and factors associated with aborted cytoreduction for peritoneal carcinomatosis
Journal of Gastrointestinal Oncology
2018;
9
(4)
:664-673
.
(01 August 2018)
The incidence of colorectal cancer in patients with previously removed polyp(s)—a cross-sectional study
Journal of Gastrointestinal Oncology
2018;
9
(4)
:674-678
.
(01 August 2018)
Chemotherapy re-challenge response rate in metastatic colorectal cancer
Journal of Gastrointestinal Oncology
2018;
9
(4)
:679-686
.
(01 August 2018)
Pencil beam scanning versus passively scattered proton therapy for unresectable pancreatic cancer
Journal of Gastrointestinal Oncology
2018;
9
(4)
:687-693
.
(01 August 2018)
Retrospective comparison of the efficacy and the toxicity of standard and modified FOLFIRINOX regimens in patients with metastatic pancreatic adenocarcinoma
Journal of Gastrointestinal Oncology
2018;
9
(4)
:694-707
.
(01 August 2018)
Role of lymph node ratio in selection of adjuvant treatment (chemotherapy vs. chemoradiation) in patients with resected gastric cancer
Journal of Gastrointestinal Oncology
2018;
9
(4)
:708-717
.
(01 August 2018)
Clinicopathologic features and outcomes of gastrointestinal stromal tumors arising from the esophagus and gastroesophageal junction
Journal of Gastrointestinal Oncology
2018;
9
(4)
:718-727
.
(01 August 2018)
Overexpression of SSH1 in gastric adenocarcinoma and its correlation with clinicopathological features
Journal of Gastrointestinal Oncology
2018;
9
(4)
:728-733
.
(01 August 2018)
Stereotactic body radiation therapy following transarterial chemoembolization for unresectable hepatocellular carcinoma
Journal of Gastrointestinal Oncology
2018;
9
(4)
:734-740
.
(01 August 2018)
Efficacy of bi-monthly hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma
Journal of Gastrointestinal Oncology
2018;
9
(4)
:741-749
.
(01 August 2018)
Is there an optimal staging system or liver reserve model that can predict outcome in hepatocellular carcinoma?
Journal of Gastrointestinal Oncology
2018;
9
(4)
:750-761
.
(01 August 2018)
Concurrent chemoradiation for resected gall bladder cancers and cholangiocarcinomas
Journal of Gastrointestinal Oncology
2018;
9
(4)
:762-768
.
(01 August 2018)
Review Article
The gut microbiome and colorectal cancer: a review of bacterial pathogenesis
Journal of Gastrointestinal Oncology
2018;
9
(4)
:769-777
.
(01 August 2018)
Case Report
Exceptional response to FOLFIRINOX in a patient with pancreatic cancer and a germline RAD51C mutation
Journal of Gastrointestinal Oncology
2018;
9
(4)
:E19-E22
.
(01 August 2018)
Unresectable metastatic colorectal cancer patient cured with cetuximab-based chemotherapy: a case report with new molecular insights
Journal of Gastrointestinal Oncology
2018;
9
(4)
:E23-E27
.
(01 August 2018)
